Efficacy of Stimulant Use for Cognitive Fluctuations in Lewy Body Dementia: A Case Study
Objective: To evaluate the effectiveness of stimulants in reducing cognitive fluctuations in Lewy Body Dementia (LBD). Background: Lewy Body Dementia (LBD) is the 2nd most…Identifying Cut-off Values, Effects of AD Co-pathology, Sex Differences, and Temporal Changes of 123I-FP-CIT SPECT in Autopsy-proven LBD
Objective: We analyzed autopsy-proven Lewy body disease (LBD) and/or Alzheimer’s disease (AD) dementia patients with 123I-FP-CIT SPECT to investigate previously unclarified detailed aspects of 123I-FP-CIT…Stepping backwards to move forward A case study on novel PT interventions for DLB
Objective: Explore the effectiveness of backwards walking and backwards stepping interventions to improve gait stability and balance in persons with Dementia with Lewy Bodies (DLB).…Association of Mitochondrial DNA Haplogroup and pS65-Ub Levels in Lewy Body Disease
Objective: To determine whether specific mitochondrial DNA (mtDNA) haplogroup(s) affect the level of p-S65-Ub as quantitative marker of mitochondrial damage in Lewy Body Disease. Background:…Comparison of Prodromal Features between Parkinson’s Disease and Dementia with Lewy Bodies over 15 Years
Objective: Compare the association of classic prodromal features with subsequent development of Parkinson’s Disease (PD) versus Dementia with Lewy Bodies (DLB). Background: DLB shares pathology…The Global Parkinson’s Genetics Program: Expanding the Diversity of Neurological Disorder Data: 2025 Update
Objective: To broaden the available data for Parkinson's Disease (PD) and related disorders by integrating genetic data from more than 115,000 participants worldwide through genotyping…Compensatory Dynamic Brain Network Mechanisms in Early Lewy Body Dementia: An rs-fMRI Study
Objective: To investigate compensatory dynamic brain network mechanisms in early Lewy body dementia (LBD), specifically mild cognitive impairment with Lewy bodies (MCI-LB), using resting-state functional…Multiplex Proteomic Analysis of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathophysiology and Progression
Objective: To evaluate the performance of a multiplexed proteomic assay in a large multi-center Lewy Body dementia (LBD) cohort. Background: LBD, which comprises Parkinson’s disease…Medication Administration Burden in Lewy Body Dementia Caregivers
Objective: To evaluate medication administration burden among Lewy Body Dementia (LBD) family caregivers and associations with caregiver and care recipient characteristics. Background: Family caregivers of…Sleep Quality among Lewy Body Dementia Family Caregivers
Objective: To explore the relationship between caregiver sleep quality and caregiver and care recipient characteristics in Lewy Body Dementia (LBD). Background: LBD family caregivers have…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 23
- Next Page »